# Pneumococcal Vaccination to Accelerate Immune Recovery in Sepsis Survivors

> **NCT03565159** · PHASE4 · COMPLETED · sponsor: **Guy's and St Thomas' NHS Foundation Trust** · enrollment: 214 (actual)

## Conditions studied

- Sepsis

## Interventions

- **BIOLOGICAL:** Prevenar 13
- **OTHER:** Sodium Chloride 0.9%

## Key facts

- **NCT ID:** NCT03565159
- **Lead sponsor:** Guy's and St Thomas' NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-02
- **Primary completion:** 2023-08-31
- **Final completion:** 2023-08-31
- **Target enrollment:** 214 (ACTUAL)
- **Last updated:** 2023-11-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03565159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03565159, "Pneumococcal Vaccination to Accelerate Immune Recovery in Sepsis Survivors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03565159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*